Skip to main content
Top
Published in: Acta Diabetologica 1/2009

01-03-2009 | Original Article

Ophthalmoplegia in diabetes mellitus: a retrospective study

Authors: Domenico Greco, Francesco Gambina, Filippo Maggio

Published in: Acta Diabetologica | Issue 1/2009

Login to get access

Abstract

Ophthalmoplegia, despite being a rare entity in diabetes mellitus, is associated with great anxiety for the patients and often appears to be a serious problem from a diagnostic and therapeutic point of view. There have been few studies primarily concerned with the relative frequencies and clinical characteristics of oculomotor neuropathies in diabetic subjects. Those published have emanated largely from neurological and/or ophthalmological referral centres rather than metabolic departments. Objective of this study was to determine the incidence, the clinical characteristics and risk factors for developing ophthalmoplegia among persons with diabetes mellitus. We have performed a retrospective study of all diabetic patients with ophthalmoplegia who were seen in the Metabolic Division at “S. Biagio” Hospital, Marsala, over the 10 year period from 1998 to 2007. A detailed history and blood laboratory profile were obtained for each patient. During the period of the survey a total of 6,765 diabetic subjects were hospitalised and ophthalmoplegia was identified in 27 patients (0.40%). Isolated III nerve palsies accounted for the majority of patients (59.3%), with VI nerve palsies (29.6%) occurring more frequently than multiple palsies (11.1%). These patients had a marked comorbidity and were found to have a poorly controlled diabetes. The patients with VI nerve palsies showed a tendency toward a higher coexistence of diabetic retinopathy and cardiovascular risk factors than those with III cranial nerve palsies. Ophthalmoplegia is a serious and not common problem among patients with diabetes mellitus; the oculomotor nerve was most frequently affected in our case-report. The fact that the coexistence of diabetic complications and cardiovascular risk factors was slightly higher in patients with VI nerve palsy is compatible with the hypothesis that this ischemic event might be more closely related to diabetes and metabolic syndrome in its pathogenesis.
Literature
1.
go back to reference Boulton AJM, Arezzo JC, Lamik RA, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27:1458–1486PubMedCrossRef Boulton AJM, Arezzo JC, Lamik RA, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27:1458–1486PubMedCrossRef
2.
go back to reference Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10:19–27PubMedCrossRef Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10:19–27PubMedCrossRef
3.
go back to reference Richards BW, Jones FR, Younge BR (1992) Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear and abducens cranial nerves. Am J Ophthalmol 113:489–496PubMed Richards BW, Jones FR, Younge BR (1992) Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear and abducens cranial nerves. Am J Ophthalmol 113:489–496PubMed
4.
go back to reference Rush JA, Younge BR (1981) Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1000 cases. Arch Ophthalmol 99:76–79PubMed Rush JA, Younge BR (1981) Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1000 cases. Arch Ophthalmol 99:76–79PubMed
5.
go back to reference Jacobson DM, McCanna TD, Layde PM (1994) Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 112:961–966PubMed Jacobson DM, McCanna TD, Layde PM (1994) Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 112:961–966PubMed
6.
go back to reference Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef
7.
go back to reference Lazzaroni F, Laffi GL, Galuppi V, Scorolli L (1993) Paralysis of oculomotor nerves in diabetes mellitus. A retrospective study of 44 cases. Rev Neurol Paris 149:571–573PubMed Lazzaroni F, Laffi GL, Galuppi V, Scorolli L (1993) Paralysis of oculomotor nerves in diabetes mellitus. A retrospective study of 44 cases. Rev Neurol Paris 149:571–573PubMed
8.
go back to reference Tiffin PA, MacEwen CJ, Craig EA, Clayton G (1996) Acquired palsy of the oculomotor, trochlear and abducens nerves. Eye 10:377–384PubMed Tiffin PA, MacEwen CJ, Craig EA, Clayton G (1996) Acquired palsy of the oculomotor, trochlear and abducens nerves. Eye 10:377–384PubMed
9.
go back to reference Berlit P (1991) Isolated and combined pareses of cranial nerves III, IV, and VI. A retrospective study of 412 patients. J Neurol Sci 103:10–15PubMedCrossRef Berlit P (1991) Isolated and combined pareses of cranial nerves III, IV, and VI. A retrospective study of 412 patients. J Neurol Sci 103:10–15PubMedCrossRef
10.
go back to reference Batocchi AP, Evoli A, Majolini L, Lo Monaco M, Padua L, Ricci E, Dickman A, Tonali P (1997) Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol 244:639–645PubMedCrossRef Batocchi AP, Evoli A, Majolini L, Lo Monaco M, Padua L, Ricci E, Dickman A, Tonali P (1997) Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol 244:639–645PubMedCrossRef
11.
go back to reference Dominguez D, Gomensoro J, Temesio P, Rodriguez-Barrios R (1974) Diabetic ophthalmoplegia. Acta Diabet Lat 11:198–205CrossRef Dominguez D, Gomensoro J, Temesio P, Rodriguez-Barrios R (1974) Diabetic ophthalmoplegia. Acta Diabet Lat 11:198–205CrossRef
12.
go back to reference Naghmi R, Subuhi R (1990) Diabetic oculomotor mononeuropathy: involvement of pupillomotor fibres with slow resolution. Horm Metab Res 22:38–40PubMedCrossRef Naghmi R, Subuhi R (1990) Diabetic oculomotor mononeuropathy: involvement of pupillomotor fibres with slow resolution. Horm Metab Res 22:38–40PubMedCrossRef
13.
go back to reference Goldstein JE, Cogan DG (1960) Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 64:592–598PubMed Goldstein JE, Cogan DG (1960) Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 64:592–598PubMed
14.
go back to reference Fraser DM, Campbell IW, Ewing DJ, Clarke BF (1979) Mononeuropathy in diabetes mellitus. Diabetes 28:96–101PubMedCrossRef Fraser DM, Campbell IW, Ewing DJ, Clarke BF (1979) Mononeuropathy in diabetes mellitus. Diabetes 28:96–101PubMedCrossRef
15.
go back to reference Tankova T, Cherninkova S, Koev D (2005) Treatment for diabetic mononeuropathy with α-lipoic acid. Int J Clin Pract 59:645–650PubMedCrossRef Tankova T, Cherninkova S, Koev D (2005) Treatment for diabetic mononeuropathy with α-lipoic acid. Int J Clin Pract 59:645–650PubMedCrossRef
16.
go back to reference Smith BE, Dyck PJ (1992) Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol 32:376–385PubMedCrossRef Smith BE, Dyck PJ (1992) Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol 32:376–385PubMedCrossRef
17.
go back to reference Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:955–966CrossRef Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:955–966CrossRef
18.
go back to reference Patel SV, Holmes JM, Hodge DO, Burke JP (2005) Diabetes and hypertension in isolated sixth nerve palsy. Ophthalmology 112:760–763PubMedCrossRef Patel SV, Holmes JM, Hodge DO, Burke JP (2005) Diabetes and hypertension in isolated sixth nerve palsy. Ophthalmology 112:760–763PubMedCrossRef
19.
go back to reference Johnson LN, Stetson SW, Krohel GB, Cipollo CL, Madsen RW (2000) Aspirin use and the prevention of acute ischemic cranial nerve palsy. Am J Ophthalmol 129:367–371PubMedCrossRef Johnson LN, Stetson SW, Krohel GB, Cipollo CL, Madsen RW (2000) Aspirin use and the prevention of acute ischemic cranial nerve palsy. Am J Ophthalmol 129:367–371PubMedCrossRef
Metadata
Title
Ophthalmoplegia in diabetes mellitus: a retrospective study
Authors
Domenico Greco
Francesco Gambina
Filippo Maggio
Publication date
01-03-2009
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2009
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0053-8

Other articles of this Issue 1/2009

Acta Diabetologica 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.